Es gab 50 kürzliche Insider-Transaktionen für Mirati Therapeutics, Inc. (MRTX), darunter 23 Käufe und 26 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $16.89M und die gesamten Insider-Verkäufe auf $34.74M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Carter Bruce L A, Gallagher Carol Giltner, Hasnain Faheem. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — MRTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-01-23 |
Carter Bruce L A |
Director |
Aktienrückgabe |
11,000 |
$64.14 |
$705.54K |
- |
| 2024-01-23 |
Gallagher Carol Giltner |
Director |
Aktienrückgabe |
12,784 |
$38.02 |
$486.05K |
- |
| 2024-01-23 |
Hasnain Faheem |
Director |
Aktienrückgabe |
10,000 |
$49.20 |
$492K |
- |
| 2024-01-23 |
Johnson Craig A |
Director |
Aktienrückgabe |
11,000 |
$64.14 |
$705.54K |
- |
| 2024-01-23 |
Sharp Shalini |
Director |
Aktienrückgabe |
7,520 |
$45.66 |
$343.36K |
- |
| 2024-01-23 |
Davis Aaron I. |
Director |
Aktienrückgabe |
11,000 |
$64.14 |
$705.54K |
- |
| 2024-01-23 |
Moriarty John B |
Chief Legal Officer |
Aktienrückgabe |
83,525 |
$45.88 |
$3.83M |
- |
| 2024-01-23 |
Baum Charles M |
Founder, President, and CEO |
Aktienrückgabe |
168,441 |
$64.14 |
$10.8M |
- |
| 2024-01-23 |
Christensen Jamie |
EVP & Chief Scientific Officer |
Aktienrückgabe |
58,750 |
$64.14 |
$3.77M |
- |
| 2024-01-23 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
Aktienrückgabe |
43,328 |
$45.66 |
$1.98M |
- |
| 2024-01-23 |
Martinez Maria E |
Director |
Aktienrückgabe |
11,000 |
$64.14 |
$705.54K |
- |
| 2024-01-23 |
Cherrington Julie M |
Director |
Aktienrückgabe |
7,520 |
$45.66 |
$343.36K |
- |
| 2024-01-23 |
Sandler Alan B. |
Chief Medical Officer |
Aktienrückgabe |
65,000 |
$59.92 |
$3.89M |
- |
| 2024-01-23 |
Ondrey Aaron |
Chief Financial Officer |
Aktienrückgabe |
11,993 |
$65.79 |
$789.02K |
- |
| 2024-01-23 |
Boxer Capital, Llc |
Other: See Remarks |
Aktienrückgabe |
1,413,475 |
$0.00 |
$1.41K |
- |
| 2024-01-16 |
Christensen Jamie |
EVP & Chief Scientific Officer |
Informierter Verkauf |
631 |
$59.02 |
$37.24K |
155,927 |
| 2024-01-16 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
Informierter Verkauf |
631 |
$59.02 |
$37.24K |
117,028 |
| 2024-01-08 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
Informierter Verkauf |
2,090 |
$58.92 |
$123.14K |
118,625 |
| 2024-01-04 |
Christensen Jamie |
EVP & Chief Scientific Officer |
Informierter Verkauf |
1,531 |
$58.81 |
$90.04K |
157,135 |
| 2023-12-29 |
Carter Bruce L A |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
17,273 |
| 2023-12-29 |
Gallagher Carol Giltner |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
14,363 |
| 2023-12-29 |
Hasnain Faheem |
Director |
RSU-Zuteilung |
9,702 |
$58.75 |
$569.99K |
24,752 |
| 2023-12-29 |
Johnson Craig A |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
17,273 |
| 2023-12-29 |
Sharp Shalini |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
16,222 |
| 2023-12-29 |
Davis Aaron I. |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
54,325 |
| 2023-12-29 |
Baum Charles M |
Interim CEO |
RSU-Zuteilung |
20,425 |
$58.75 |
$1.2M |
247,700 |
| 2023-12-29 |
Christensen Jamie |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
17,021 |
$58.75 |
$999.98K |
158,666 |
| 2023-12-29 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
17,021 |
$58.75 |
$999.98K |
120,715 |
| 2023-12-29 |
Martinez Maria E |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
17,273 |
| 2023-12-29 |
Cherrington Julie M |
Director |
RSU-Zuteilung |
6,808 |
$58.75 |
$399.97K |
11,252 |
| 2023-12-29 |
Sandler Alan B. |
Chief Medical Officer |
RSU-Zuteilung |
17,021 |
$58.75 |
$999.98K |
79,318 |
| 2023-12-29 |
Ondrey Aaron |
CFO |
RSU-Zuteilung |
17,021 |
$58.75 |
$999.98K |
39,461 |
| 2023-12-18 |
Christensen Jamie |
EVP & Chief Scientific Officer |
Informierter Verkauf |
2,387 |
$57.50 |
$137.25K |
141,645 |
| 2023-12-18 |
Ecor1 Capital, Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
7,396,979 |
| 2023-12-13 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
Informierter Verkauf |
2,220 |
$56.67 |
$125.81K |
103,694 |
| 2023-09-08 |
Christensen Jamie |
EVP & Chief Scientific Officer |
Informierter Verkauf |
2,388 |
$35.63 |
$85.08K |
144,032 |
| 2023-09-08 |
Ondrey Aaron |
Interim CFO |
Veräußerung |
11,844 |
$45.66 |
$540.8K |
- |
| 2023-09-08 |
Ondrey Aaron |
Interim CFO |
RSU-Zuteilung |
8,412 |
$35.66 |
$299.97K |
22,440 |
| 2023-08-11 |
Hasnain Faheem |
Director |
Informierter Kauf |
10,791 |
$27.80 |
$299.99K |
10,791 |
| 2023-08-11 |
Boxer Capital, Llc |
Officer |
Informierter Kauf |
57,533 |
$27.80 |
$1.6M |
287,866 |
| 2023-08-09 |
Moriarty John B |
Chief Legal Officer |
RSU-Zuteilung |
22,297 |
$37.00 |
$824.99K |
71,660 |
| 2023-08-09 |
Baum Charles M |
Interim CEO |
RSU-Zuteilung |
54,054 |
$37.00 |
$2M |
227,275 |
| 2023-08-09 |
Christensen Jamie |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
22,297 |
$37.00 |
$824.99K |
146,420 |
| 2023-08-09 |
Stelzer Laurie |
Chief Financial Officer |
RSU-Zuteilung |
22,297 |
$37.00 |
$824.99K |
102,312 |
| 2023-08-09 |
Hickey Benjamin |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
22,297 |
$37.00 |
$824.99K |
105,914 |
| 2023-08-09 |
Sandler Alan B. |
Chief Medical Officer |
RSU-Zuteilung |
22,297 |
$37.00 |
$824.99K |
62,297 |
| 2023-06-23 |
Moriarty John B |
Chief Legal Officer |
Veräußerung |
83,525 |
$45.88 |
$3.83M |
- |
| 2023-06-22 |
Gallagher Carol Giltner |
Director |
Veräußerung |
- |
- |
- |
- |
| 2023-06-22 |
Gallagher Carol Giltner |
Director |
RSU-Zuteilung |
7,555 |
- |
- |
7,555 |
| 2023-06-02 |
Stelzer Laurie |
Chief Financial Officer |
Informierter Verkauf |
4,647 |
$37.06 |
$172.22K |
80,015 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
